APLM (Apollomics Corp) Sof marja

APLM (Apollomics) - kompaniyaning tovar belgisi

Apollomics, Inc. o'z laboratoriyalarida qat'iy ekologik xavfsizlik protokollarini joriy qilmoqda. Joriy savdo marjalari ushbu xarajatlarni aks ettirmoqda, bunda 0.00 ushbu baholash parametrini tavsiflaydi. Ushbu tendentsiya Xitoyning R&D (tadqiqot va ishlanmalar) tizimiga bog'liqlik hamda BioSecure Act bilan bog'liq geosiyosiy xatarlar ta'sirida yuzaga kelmoqda. Tijorat mahsulotlarining yo'qligi va barqaror pul oqimining mavjud emasligi kompaniyaning moliyaviy holatini ventura kapital investitsiyalari va klinik sinovlar natijalariga bog'liq qilib qo'ymoqda.

Apollomics (APLM) Sof marja: 21.02.2024 - 19.11.2026 davri uchun

apollomicsinc.com (APLM) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Apollomics, Inc.
Apollomics, Inc. yetakchi tovari

Yuqori sifatli portfelni shakllantirish uchun men daromadning sof foydaga aylanish samaradorligini baholayman. Ushbu metrika barcha operatsion va soliq xarajatlari chegirilgandan so'ng, sotuvlarning har bir dollari uchun qolgan qoldiq daromad ulushini o'lchaydi. Apollomics, Inc. (APLM) holatida, ushbu ko'rsatkich yopiq ilmiy zanjirni saqlash xarajatlarini va klinik dasturlar bilan bog'liq xarajatlarni aks ettiradi. Sotuvlarning bir birligi uchun sof foydani tahlil qilish orqali investor maqsadli dori vositalarini ishlab chiqishning real xarajatlarini ko'rishi mumkin. Ushbu ko'rsatkichning tendentsiyasi biofarmatsevtika ekotizimining inflyatsiyaviy bosimga chidamliligini namoyish etadi.

Apollomics, Inc. (APLM) raqobatchilari

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|TScan Therapeutics (TCRX) - Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology|Sof marja XBIT|Sotuvning sof marjinal rentabelligi CVM|Sof foyda bo'yicha sotuv rentabelligi OS Therapies Inc. OSTX|Sof marja Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Sof marja|ANL - Sof marja|Sof marja verupharma.com|TPST: Sotuvning sof marjinal rentabelligi|XLO - Kompaniya sotuv marjasi|Sof marja Renovaro|Sotuvning sof marjinal rentabelligi muraloncology.com|Sotuvning sof marjinal rentabelligi KAPA|Kompaniya sotuv marjasi OnKure Therapeutics, Inc.|Sotuvning sof marjinal rentabelligi GDTC (w2.cytomed.sg)|CRIS - Sof foyda bo'yicha sotuv rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)